What Fueled The Previous Growth In The Controlled Release Drug Delivery Market?
The controlled release drug delivery market has seen considerable growth due to a variety of factors.
• The market size of controlled drug delivery systems has seen a significant expansion in the last few years. The expected progression is from $65.44 billion in 2024 to $73.01 billion in 2025, with a compound annual growth rate (CAGR) of 11.6%. The substantial growth made in the past is due to factors such as novel drug delivery systems, the inception of polymer-based formulations, the advent of microencapsulation methods, the emergence of transdermal delivery, official authorizations and standardization.
What Is The Expected Growth In The Controlled Release Drug Delivery Market Size Evolve over the Forecast Period?
The Controlled Release Drug Delivery market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for controlled release drug delivery is predicted to undergo a quick expansion in the upcoming years. It is expected to reach a value of $119.41 billion by 2029, with a compound annual growth rate (CAGR) of 13.1%.
This surge during the forecast period is linked to the shift towards personalized medicine, integration of technology for patient ease, proliferation of biologics and biosimilars, market growth in emerging regions and progress in polymer science. The key trends during the forecast timeline are anticipated to be biodegradable and biocompatible materials, progress in nanotechnology, personalized medicine and targeted therapies, advancements in implantable devices, and novel encapsulation methods.
What Main Forces Are Fueling Expansion In The Controlled Release Drug Delivery Market?
The increasing incidence of chronic conditions is anticipated to drive the expansion of the controlled release drug delivery market. Chronic diseases, also referred to as noncommunicable diseases, represent conditions like heart disease, cancer, and diabetes, which require ongoing medical attention or restrict daily activities, or both, and last over a year. The administration of controlled-release drugs is pivotal in managing these long-lasting diseases. For those suffering from chronic diseases that need long-term medical treatment, or those living in regions with limited healthcare access and resources, drug delivery systems enabling extended medication release are a necessity. As per data from the World Health Organization (WHO), a health-dedicated agency based in Switzerland, in September 2022, chronic diseases are responsible for the annual death of 41 million individuals, accounting for 74 percent of total deaths globally. Chronic diseases cause 17 million people to pass away before reaching 70, and 77 percent of chronic disease casualties occur in lower- and middle-income countries and these numbers are set to increase. Hence, the escalating prevalence of chronic conditions is fuelling the growth of the controlled release drug delivery market.
What Are The Primary Segments In The Global Controlled Release Drug Delivery Market?
The controlled release drug delivery market covered in this report is segmented –
1) By Technology: Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, Other Technologies
2) By Release Mechanism: Polymer Based Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems, Activation-Modulated Drug Delivery Systems, Chemically Activated,
3) By Application: Metered Dose Inhalers, Injectable, Transdermal And Ocular Patches, Other Applications
4) By End User: Hospitals, Clinics, Personal, Research, Other End Users
Subsegments:
1) By Wurster Technique: Spray Coating, Fluid Bed Coating
2) By Coacervation: Simple Coacervation, Complex Coacervation
3) By Micro Encapsulation: Polymer-Based Micro Encapsulation, Lipid-Based Micro Encapsulation
4) By Implants: Biodegradable Implants, Non-Biodegradable Implants
5) By Transdermal: Microneedle Patches, Reservoir Systems, Matrix Systems
6) By Targeted Delivery: Nanoparticles, Antibody-Drug Conjugates, Liposomes
7) By Other Technologies: Osmotic Pumps, In Situ Gelling Systems
Pre-Book The Controlled Release Drug Delivery Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Key Trends Are Driving Changes In The Controlled Release Drug Delivery Market?
Embracing technological innovations is a trending strategy adopted by key players in the controlled-release drug delivery industry. Major firms in this sector are using new tech advancements to maintain their market stronghold. For example, Evonik Industries AG, a pharmaceutical company based in Germany, unveiled UDRATEC SoluFlow in March 2022. This innovative microparticle technology enhances the solubility of active ingredients in oral medicines, resolving solubility challenges that traditional manufacturing methods fail to resolve. EUDRATEC SoluFlow supplements Evonik Health Care's assortment of oral drug delivery solutions, including oral excipients like EUDRAGIT functional polymers and ready-to-fill functional capsules such as EUDRACAPTM, coupled with various technologies and services to optimize medicine effectiveness.
Who Are the Key Players In The Controlled Release Drug Delivery Market?
Major companies operating in the controlled release drug delivery market include:
• Johnson & Johnson Services Inc.
• Merck & Co. Inc.
• Alkermes plc
• Coating Place Inc.
• Corium International Inc.
• Depomed Inc.
• Pfizer Inc.
• Aradigm Corporation
• Capsugel LLC
• GlaxoSmithKline plc
• Bayer Healthcare LLC
• Collegium Pharmaceuticals Inc.
• GE HealthCare Technologies Inc.
• Adare Pharmaceuticals Inc.
• Allergan plc
• Novartis AG
• Lonza Group AG
• Colorcon Inc.
• SKY Pharmaceuticals Pvt. Ltd.
• AstraZeneca plc
• Biogen Inc.
• Orbis Biosciences Inc.
• Alza Corporation
• MicroCHIPS Inc.
• Endo International plc
• Heron Therapeutics Inc.
• Intellipharmaceutics International Inc.
• Ipsen Biopharmaceuticals Inc.
• Luye Pharma Group Ltd.
• Medtronic plc
• Nektar Therapeutics
• Novo Nordisk A/S
• Ocular Therapeutix Inc.
• Pacira BioSciences Inc.
• Progenity Inc.
• Sanofi S.A.
• Teva Pharmaceutical Industries Ltd.
• Titan Pharmaceuticals Inc.
• Vectura Group plc
• West Pharmaceutical Services Inc.
• Zosano Pharma Corporation
• Zynerba Pharmaceuticals Inc.
What Is The Most Dominant Region In The Controlled Release Drug Delivery Market?
North America was the largest region in the controlled release drug delivery market in 2024. The regions covered in the controlled release drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
